Skip to main content
Fig. 2 | Alzheimer's Research & Therapy

Fig. 2

From: Baseline [18F]GTP1 tau PET imaging is associated with subsequent cognitive decline in Alzheimer’s disease

Fig. 2

Annualized longitudinal cognitive change using estimated slopes derived from A simple linear and B linear mixed effect models on the Mini-Mental State Exam (MMSE), Clinical Dementia Rating Sum of Boxes (CDR-SB), 13-item version of the Alzheimer’s Disease Assessment Scale-Cognitive Subscale (ADAS-Cog13), and Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) Total Index in the cognitively normal (CN) and prodromal (Pro), mild (Mild), and moderate (Mod) AD groups. Error bars indicate a 95% confidence interval. ap < 0.05 vs. CN; bp < 0.05 vs. Pro

Back to article page